VEGFA and exocrine pancreatic carcinoma: According to one study, applying nsPEF to the human pancreatic carcinoma cell line (PANC-1) can change the protein expression of the Wnt/β-catenin signaling pathway, matrix metalloproteinases (MMP) family, and vascular endothelial growth factor (VEGF).